Merriman Curhan Ford Initiates Coverage on Antares Pharma (AIS) with a Buy; Cutting Edge Drug Delivery Business
Tweet Send to a Friend
Merriman Curhan Ford initiates coverage on Antares Pharma, Inc. (NYSE: AIS) with a Buy.
Merriman analyst says, "We believe Antares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Merriman analyst says, "We believe Antares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
